Division of Viral Pathogenesis, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Mucosal Immunol. 2013 Jan;6(1):156-66. doi: 10.1038/mi.2012.59. Epub 2012 Jul 18.
Vaccination strategies for protection against a number of respiratory pathogens must induce T-cell populations in both the pulmonary airways and peripheral lymphoid organs. In this study, we show that pulmonary immunization using plasmid DNA formulated with the polymer polyethyleneimine (PEI-DNA) induced antigen-specific CD8(+) T cells in the airways that persisted long after antigen local clearance. The persistence of the cells was not mediated by local lymphocyte proliferation or persistent antigen presentation within the lung or airways. These vaccine-induced CD8(+) T cells effectively mediated protective immunity against respiratory challenges with vaccinia virus and influenza virus. Moreover, this protection was not dependent upon the recruitment of T cells from peripheral sites. These findings demonstrate that pulmonary immunization with PEI-DNA is an efficient approach for inducing robust pulmonary CD8(+) T-cell populations that are effective at protecting against respiratory pathogens.
针对多种呼吸道病原体的保护疫苗接种策略必须在肺部气道和外周淋巴器官中诱导 T 细胞群体。在这项研究中,我们表明,使用聚合物聚乙烯亚胺(PEI-DNA)配制的质粒 DNA 进行肺部免疫接种可在抗原局部清除后很长时间内在气道中诱导抗原特异性 CD8(+)T 细胞。细胞的持久性不是通过肺或气道中局部淋巴细胞增殖或持续抗原呈递介导的。这些疫苗诱导的 CD8(+)T 细胞有效地介导了对牛痘病毒和流感病毒呼吸道挑战的保护性免疫。此外,这种保护不依赖于从外周部位募集 T 细胞。这些发现表明,使用 PEI-DNA 进行肺部免疫接种是一种有效的方法,可以诱导有效的肺部 CD8(+)T 细胞群体,有效抵御呼吸道病原体。